Dai-ichi Life Insurance Company’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,719	Closed	-$1.02M	–	530
2022 Q1	$1.02M	Hold	9,719	–	–	0.02%	418
2021 Q4	$1.05M	Buy	9,719 +7,309	+303%	+$797K	0.01%	418
2021 Q3	$264K	Hold	2,410	–	–	﹤0.01%	511
2021 Q2	$226K	Hold	2,410	–	–	﹤0.01%	543
2021 Q1	$222K	Buy	+2,410	New	+$203K	﹤0.01%	533

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Dai-ichi Life Insurance Company's HZNP Position: Q2 2022 in Review

Dai-ichi Life Insurance Company sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2022, closing a stake of 9,719 shares — an estimated $1.02M sold.

Dai-ichi Life Insurance Company first reported a position in HZNP in Q1 2021 and held it in 5 quarters. The position peaked at $1.05M in Q4 2021. 616 funds tracked by Wall St. Rank hold HZNP as of Q2 2022.

Dai-ichi Life Insurance Company reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Dai-ichi Life Insurance Company sold 9,719 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2022, an estimated $1.02M.
Dai-ichi Life Insurance Company first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021 and held it in 5 quarters.
Dai-ichi Life Insurance Company's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.05M in Q4 2021.
616 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2022.

Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2022, filed 12 Aug 2022.